您现在的位置: 首页> 研究主题> 4,4'-联吡啶

4,4'-联吡啶

4,4'-联吡啶的相关文献在1998年到2021年内共计62篇,主要集中在化学、晶体学、基础医学 等领域,其中期刊论文58篇、会议论文4篇、专利文献19008篇;相关期刊35种,包括衡阳师范学院学报、洛阳师范学院学报、延安大学学报(自然科学版)等; 相关会议3种,包括第八届全国X射线衍射学术会议、中国化学会全国第五届无机化学学术会议、全国第十九届大环化学暨第十一届超分子化学学术讨论会等;4,4'-联吡啶的相关文献由222位作者贡献,包括刘立新、张羽男、梁福沛等。

4,4'-联吡啶—发文量

期刊论文>

论文:58 占比:0.30%

会议论文>

论文:4 占比:0.02%

专利文献>

论文:19008 占比:99.67%

总计:19070篇

4,4'-联吡啶—发文趋势图

4,4'-联吡啶

-研究学者

  • 刘立新
  • 张羽男
  • 梁福沛
  • 陈自卢
  • 黄妙龄
  • 刘峥
  • 匡海学
  • 崔颜
  • 张勇
  • 张大俊
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 肖忠伟; 杨钊; 徐红; 李敏; 赵永凤
    • 摘要: 目的 以5-氟尿嘧啶(5-FU)为活性药物成分,4,4'-联吡啶(BPY)为共晶配体,运用共结晶技术制备一种新的5-FU-BPY共晶,并对该共晶进行结构表征及性质研究.方法 采用结合超声技术的溶剂蒸发法制备共晶,使用X-射线单晶衍射(SCXRD)测定单晶结构,通过X-射线粉末衍射(PXRD)、差示扫描量热法(DSC)、傅里叶变换红外光谱法(FT-IR)、扫描电镜(SEM)对共晶进行表征分析.结果 5-FU与BPY以4:1的化学计量比形成共晶.SCXRD测定结果表明,该晶体属于单斜晶系,P21/c空间群.5-FU-BPY的PXRD图谱在衍射角2θ为12.94°、14.90°、16.78°及33.83°处有新的特征衍射峰.DSC结果显示,5-FU-BPY在256.66°C处具有新的熔点峰.FT-IR分析结果显示,5-FU在3068、1725/cm处对应的亚酰胺基伸缩振动峰以及BPY在1401/cm处对应的吡啶氮伸缩振动峰均发生位移.SEM下该共晶呈现出不同于5-FU和BPY的长条状形态.结论 一种具有新熔点的5-FU-BPY新晶相形成.FT-IR结果表明5-FU的亚酰胺基和BPY的吡啶氮参与了5-FU-BPY结构中氢键的形成.SCXRD结构研究揭示,4个5-FU分子通过分子间氢键相连形成超分子环形单元,中间连接1个BPY分子,形成双孔状环形结构,这种罕见的超分子孔洞结构将对共晶的理化性质产生一定影响.
    • 苏雅静; 樊婷婷; 张美娜; 李夏
    • 摘要: A metal-organic framework [Zn (3 ,4'-Hdpdc)2(4 ,4'-bpy)] (Zn-MOF) has been synthesized by hydrothermal reac-tion with the Zn(NO3)2·6H2O ,3 ,4'-biphenyl dicarboxylic acid (3 ,4'-H2dpdc) and 4 ,4'-bipyridine (4 ,4'-bpy) ,and its crys-tal structure was confirmed by X-ray single crystal diffraction .The complex was the monoclinic system ,C2/c space group .The complex had a "Z"-shaped chain structure formed by the 4 ,4'-bpy ligand and Zn(Ⅱ) ion .The Zn-MOF exhibited intense ligand-based blue luminescence with the maximum excitation wavelength of 278 nm ,and the emission band was in the range of 341~537 nm from the π*—π transition of the ligand .The emission maximum was at 406 nm .The luminescence properties of the complex toward Ln(Ⅲ) metal ions in methanol/aqueous solutions were studied .Fluorescence spectrum show the characteristic emission peaked of Tb (Ⅲ) ions at 490 ,545 ,585 and 624 nm ,which corresponded to 5D4→ 7FJ(J=6~3) transitions of Tb (Ⅲ) ,the strongest emission peaked at 545 nm (5D4→ 7F5) ,for the green light .The experimental results showed that the Zn-MOF can sensitize the Tb(Ⅲ) ion in the methanol solution and in water ,and thus the compound can be used as a fluorescent probe to detect Tb(Ⅲ) ions in methanol solutions and in water .%以硝酸锌与3 ,4'-联苯二甲酸(3 ,4'-H2dpdc) ,4 ,4'-联吡啶(4 ,4'-bpy)为反应物,以水为溶剂,适当调节pH值,通过水热反应,得到配合物[Zn(3 ,4'-Hdpdc)2(4 ,4'-bpy)](Zn-MOF).利用X射线单晶衍射测试分析确定了该配合物是由4 ,4'-bpy配体桥联Zn(Ⅱ)离子形成的"Z"形链结构,属于单斜晶系,C2/c空间群.在278 nm激发下,Zn-MOF的荧光发射光谱在341~537 nm范围出现宽发射峰,最强发射峰波长406 nm ,属于配体的π*—π跃迁.研究了该配合物对Tb(Ⅲ)离子发光性能的影响.实验结果表明,Zn-MOF可敏化甲醇和水溶液中的T b(Ⅲ)离子,使T b(Ⅲ)离子的特征荧光发射峰增强.在荧光光谱490 ,545 ,585和624 nm出现强的线状发射峰,对应于 T b (Ⅲ)离子的5D4→ 7FJ( J=6~3)跃迁.最强发射峰位于545 nm (5D4→ 7F5) ,为绿光.Zn-MOF可用作荧光探针检测甲醇和水溶液中的Tb(Ⅲ)离子.
    • 刘立新; 邹冬玉; 张羽男; 张强; 张楠楠
    • 摘要: 目的:研究木犀草素·4,4'-联吡啶药物共晶的抗炎作用及机制.方法:以正常小鼠巨噬细胞RAW264.7为对照,以脂多糖(LPS)诱导的RAW264. 7细胞为炎症模型,采用MTT法检测不同浓度(10、20、40、80 μmol/L)的木犀草素、4,4'-联吡啶和木犀草素-4, 4'-联吡啶药物共晶作用细胞2 h后的细胞活性;荧光定量聚合酶链式反应法测定40 μmol/L浓度时细胞中诱导型一氧化氮合酶(iNOS)、环氧合酶2(COX-2)mRNA的表达,酶联免疫吸附法测定40 μmol/L浓度时细胞中肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)蛋白表达,Western blot法测定40 μmol/L浓度时细胞中核转录因子p65 (NF-κB p65)蛋白表达.结果:与正常细胞比较, LPS诱导后RAW264. 7细胞活性明显降低(P<0. 01),iNOS和COX-2 mRNA表达水平及TNF-α、IL-6、NF-κB p65蛋白表达水平均明显升高(P<0. 01).木犀草素和木犀草素·4,4'-联吡啶药物共晶均能增强LPS诱导后RAW264. 7细胞活性(P<0. 05或P<0. 01), 且呈浓度依赖性;4,4'-联吡啶对LPS诱导后RAW264. 7细胞活性无明显影响;40 μmol/L浓度下,木犀草素和木犀草素·4, 4'-联吡啶药物共晶可使LPS诱导后细胞中iNOS和COX-2 mRNA表达水平及TNF-α、IL-6、NF-KB p65蛋白表达水平明显降低(P<0. 05或P<0. 01),其中木犀草素-4,4'-联吡啶药物共晶降低效果强于木犀草素(P<0. 05或P<0. 01).结论:木犀草素·4,4'-联吡啶药物共晶可能通过下调NF-κB信号来抑制炎症相关因子产生,其抗炎作用优于木犀草素.%OBJECTIVE: To study anti-inflammatory effect and mechanism of the luteolin · 4, 4' -dipyridy co-crystal.METHODS: Using macrophage RAW264. 7 of normal mice as control, the inflammation model was established with lipopolysaccharide (LPS) -induced RAW264. 7 cells. MTT assay was used to detect cells activity 2 h after treatment of different concentrations of luteolin (10, 20, 40, 80 μmol/L), 4, 4' -dipyridy (10,20, 40,80 μmol/L) and luteolin·4, 4' -dipyridy co-crystal (10, 20, 40, 80 μmol/L). The mRNA expression of iNOS and COX-2 in RAW264. 7 cells at 40 μmol/L were determined by qRT-PCR. The protein expression of TNF-α and IL-6 in RAW264. 7 cells at 40 μmol/L were determined by ELISA. The protein expression of NF-κB p65 in RAW264. 7 cells at 40 μmol/L were determined by Western bolt. RESULTS: Compared with normal cells, the activity of RAW264. 7 cells was decreased significantly after induced by LPS (P<0. 01); mRNA expression of iNOS and COX-2, protein expression of TNF-α, IL-6 and NF-κB p65 were increased significantly (P<0. 01). Both luteolin and luteolin · 4, 4' -dipyridy co-crystal could enhance the activity of RAW264. 7 cells after induced by LPS (P<0. 05 or P<0. 01) in concentration-dependent manner. 4, 4' -dipyridy had no significant effect on the activity of RAW264. 7 cells after induced by LPS. After luteolin and luteolin· 4, 4' -dipyridy co-crystal at 40 μmol/L, mRNA expression of iNOS and COX-2, protein expression of TNF-α, IL-6 and NF-κB p65 in RAW264. 7 cells after induced by LPS were decreased significantly (P<0. 05 or P<0. 01); the luteolin · 4, 4' -dipyridy co-crystal was better than luteolin (P<0. 05 or P<0. 01). CONCLUSIONS: The luteolin·4, 4' -dipyridy co-crystal can inhibit the generation of inflammatory factors by down-regulating NF-κB signal, and its anti-i nflammatory effect is better than luteolin.
    • 刘峥军; 陈晓淼; 刘凌云
    • 摘要: 以对氯苯磺酰谷氨酸为第一配体,分别以邻菲罗啉和4,4'-联吡啶为第二配体,采用溶剂热合成法合成对氯苯磺酰谷氨酸?邻菲罗啉合锌(Ⅱ)和对氯苯磺酰谷氨酸?(4,4'-联吡啶)合锌(Ⅱ)两个配合物,通过红外光谱初步确定成功合成得到了两个目标配合物,并通过荧光光谱测试了其发光性能.
    • 覃妍; 肖瑜; 黄浦; 朱芸; 易茗
    • 摘要: 采用溶液法合成了一维链状4,4'-联吡啶铜配合物{[Cu2(OOCCH3)4(4,4-bpy)]·(CHaCN)}n(4,4-bpy=4,4'-联吡啶),经单晶X射线衍射测定其晶体结构.此晶体属单斜晶系,空间群C2/c.晶胞参数:a=2.311 67(5)nm,b =1.400 23(2)nm,c=1.531 03(4)nm,β=108.205(2)°,V=4.707 69(17)nm3,F(000) =2 288,Z=8,D.=1.582 g/em3,μ=1.850mm-1,R1=0.033 6,ωoR2=0.093 5.晶体结构分析表明,配合物中心Cu2形成了变形的几何四方锥CuNO4构型,Cu2通过4个乙酸根桥连形成双核单元,双核单元再通过4,4'-联吡啶N原子桥联成一维链状,经分子间范德华力作用构造出了三维超分子网.%The title complex was synthesized in the reaction by 4,4'-bipyridine and cupric acetate in acetonitrile DMF solution.The crystal structure was determined by single crystal X-ray diffraction.The crystal structure of the title complex belongs to the monoclinic system with space group C2/c and cell parameters:a =2.311 67 (5) nm,b=1.40023(2) nm,c=1.531 03(4) nm,β=108.205(2)°,V=4.707 69(17) nm3,F(000)=2 288,Z =8,Dc =1.582 g/cm3,μ =1.850 mm-1,R1 =0.033 6,ωR2 =0.093 5.The Cu(Ⅱ) was coordinated by four oxygen atoms from OOCCH3 groups and one nitrogen atom from 4,4'-bipyridine,and formed a distorted square pyramidal geometrical configuration.The complex formed a dimer through OOCCH3 bridges which constructed a one dimensional chain.The 1D chain further formed 3D network through the van der Waals force.
    • 赵仑; 白鹤龙; 孙二军; 王晓峰; 王子忱
    • 摘要: 在水热体系中合成了3个中心金属为镍离子,以六配位扭曲八面体构型形成的具有螺旋结构的配位聚合物{[Ni2L2(bib)2·2H2O]·5H2O}n(1),[Ni2L2(bpy)]n(2)和{[Ni2L2 (bibpip)2·2H2O]·6H2O}n(3)[H2L=4,4'-三苯胺二甲酸;bib=1,3-二(咪唑基)苯;bpy=4,4-联吡啶;bibpip=1,4-二(4-咪唑苄基)哌嗪].通过单晶及粉末X射线衍射、红外光谱、元素分析和热重分析对这3种化合物进行了表征.结果表明,化合物1属于单斜晶系,C2/c空间群,其骨架为具有{42·65 ·8}拓扑结构的二维层结构;化合物2属于斜方晶系,Fdd2空间群,其骨架为具有{48 ·54 ·63}拓扑结构的三维超分子网络;化合物3属于三斜晶系,P1空间群,为1个五重穿插的三维超分子网络,其骨架具有{44 ·62}拓扑结构.
    • 叶文鹏; 陈铭; 杨意; 查丽琴; 马运声; 袁荣鑫
    • 摘要: 在水热条件下,以N-氧化-2-吡啶膦酸(H2L)为主配体,4,4'-联吡啶(bpy)为桥联配体,合成了3个铜有机膦酸配合物:{[Cu(L)(bpy)0.5(H2O)]·2H2O}n(1),([Cu(HL)2(bpy)]·4H2O}n(2)和([Cu2(L)2(bpy)]· 3H2O}n(3).配合物1中,相邻的铜离子由2个膦酸根连成二聚体,二聚体之间通过bpy桥联成一维链.配合物2中,单核[Cu(HL)2]被bpy连接成一维链.配合物3中,四聚体[Cu2(L)2]2被bpy连接成“砖块状”结构的二维层.磁性研究表明,配合物1和3中铜离子之间存在反铁磁性耦合.
    • 石显璘; 郑长征; 薛凝; 杨森; 武耀博
    • 摘要: 以1,2,4,5-苯四甲酸(H4 BTA)为主要配体,加入辅配4,4 '联吡啶(bipy)和金属盐Zn(NO3)2·6H2O,通过水热法合成出一个Zn(Ⅱ)的配合物晶体[Zn(H2 BTA) (bipy)(H2 O)]n.通过元素分析、红外光谱、X-射线单晶洐射、热重分析和X-射线粉末衍射等手段对此配合物的特性进行表征.X-射线单晶衍射结果表明,此配合物属于单斜晶系,P21空间群,晶胞参数为a=0.948 9(3)nm,b=0.727 4(2)nm,c=1.625 2(4)nm,α=90.00°,β=95.22(4)°,γ=90.00°,V=1.117 11(50)nm3,Z=4;热重分析结果表明其具有较好的稳定性;X-射线粉末洐射分析结果表明其具有较高纯度.
    • 张羽男; 殷和美; 张宇; 赵巍; 刘立新; 张大俊; 匡海学
    • 摘要: 利用溶液挥发法首次合成1个全新的木犀草素-4,4'-联吡啶药物共晶,并通过红外光谱、核磁共振、X射线粉末衍射及差示扫描热量分析等对其表征.选择不同物质量比的木犀草素与4,4'-联吡啶及不同反应溶剂为主要影响因素,探索并确定相应合成条件:木犀草素和4,4'-联吡啶以1:3的物质量比混合后溶于7.0 mL丙酮溶剂,25°C下搅拌3h后,于室温下挥发,5d后得到黄褐色粉末状晶体.结果表明,在极性相对较小的溶剂体系中,反应物分子间形成数目合适且方向饱和的氢键连接,可有效促进药物共晶生成.
    • 李家明; 史忠丰
    • 摘要: 以Co(NO3)2·6H2O,1H苯并三氮唑-1-乙酸和4,4'-联吡啶(4,4'-bipy)为原料,采用溶剂蒸发法合成了一种具有(4,4)-连接(44· 62)拓扑结构的新型一维链状钴配合物{[Co(4,4'-bipy)3(OH)2]n(1)},其结构经FT-IR,元素分析,X-射线单晶衍射表征.1(CCDC:1 041 543)属单斜晶系,空间群C2/c,晶胞参数a=18.057(4)A,b=11.487(2)A,c=24.590(5)A,β=93.60(3)°, V=5 090.4(18) A3, Z=4, Dc =0.733 g·cm-3,μ=0.358 mm-1,F(000)=1 144,R1=0.093 0,ωR2=0.192 2.1的中心离子Co(Ⅱ)与4个氮原子和2个氧原子配位,形成畸变的八面体几何构型.未参与桥联的4,4'-bipy形成分子间氢键(O-H…N)和π…π堆积,进一步将一维链结构扩展为二维(4,4)-连接(44· 62)拓扑的超分子网状结构.表面光电压光谱研究结果表明:1在300 nm~600 nm内有正光伏响应,具有一定的光转换能力.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号